Medical Center – University Of Freiburg

Hugstetter Strasse 55, Stuehlinger, Freiburg Im Breisgau, 79106, Germany

Neoplasms

The Klinik für Strahlenheilkunde at the Medical Center – University Of Freiburg conducts cutting‑edge research in radiation oncology, concentrating on aggressive brain tumors such as glioblastoma and astrocytoma.

Evaluation of a novel vaccine for surgically resected glioblastoma
Investigation of therapeutic strategies for astrocytoma with unmethylated molecular signature
Assessment of safety and optimal dosing in post‑surgical patients

The site is located in Freiburg Im Breisgau, Germany, supports 7 active clinical studies and involves a team of over 125 investigators dedicated to improving outcomes for patients with malignant brain tumors.

Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

Recruiting

3 1 1
Investigated Drugs:
+6
Phase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments

Recruiting

3 1 1
Investigated Diseases:
- Plasma cell myeloma refractory
Investigated Drugs:
- IGG1 TRISPECIFIC MONOCLONAL ANTIBODY AGAINST T-CELL RECEPTOR CD3, B-CELL MATURATION ANTIGEN AND G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D
- Teclistamab
+1
Phase 1/2 Study Evaluating Safety and Activity of GSK5926371 in Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Recruiting

1 1 1
Investigated Diseases:
- Non-Hodgkin’s lymphoma
Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

Recruiting

2 1

+4
Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

Recruiting

3 1 1 1
Investigated Diseases:
- Oesophageal adenocarcinoma
- Gastric cancer
Investigated Drugs:
+2
Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

Recruiting

3 1 1
Investigated Drugs:
- Sarilumab
- Prednisone
+3
Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

Recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Small cell lung cancer
Investigated Drugs:
- Topotecan Hydrochloride
+5
A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Recruiting

3 1 1 1
Investigated Drugs:
- Ro7589655
- Simoctocog Alfa
+3
Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

Recruiting

3 1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Emicizumab
- Ro7589655
+5